MedTrace Logo

General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial

NCT03034096 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1826

Last updated 2025-05-04

No results posted yet for this study

Summary

This is a large pragmatic multicenter trial comparing maintenance of general anesthesia with total intravenous anesthesia using propofol versus volatile agent (sevoflurane, isoflurane, or desflurane) during cancer surgery. The primary endpoint is all-cause mortality.

Conditions

  • Anesthesia, General
  • Surgical Oncology

Interventions

DRUG

Propofol

Maintenance of general anesthesia with propofol infusion

DRUG

Volatile Agent

Maintenance of general anesthesia with volatile agent (sevoflurane, desflurane, or isoflurane)

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2024-09-30
Completion
2024-09-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03034096 on ClinicalTrials.gov